Although further refinement and testing is needed, Dr. Burgess said the new techniques have the potential to speed the production of many different types
of transgenic animal models that will shed new light on human development and disease.
Not exact matches
Known as a triple
transgenic model, the
animals develop three key characteristics
of the disease: memory impairment, amyloid plagues, and neurofibrillary tangles.
The finding, by researchers at the University
of Illinois at Chicago College
of Medicine, was reported July 16 at the Alzheimer's Association International Conference in Copenhagen by Mary Jo LaDu, who in 2012 developed a
transgenic mouse that is now regarded as the best
animal model of the human disease.
Dean LaFerla has several research interests, including the molecular biology
of Alzheimer's disease and other neurodegenerative disorders, presenilins and calcium signaling, learning and memory, and
transgenic and genetically modified
animal models.
His lab develops isogenic human pluripotent stem cells and
transgenic animals to
model disease, with the goal
of delineating novel approaches to influence outcomes for Huntington disease (HD) and Fragile X Syndrome (FXS), the most common genetic causes
of dementia and intellectual disability, respectively.
We are organizing joint meeting with our colleagues from Masaryk University in Brno dedicated to current progress in
transgenic technologies in research application,
animal models of diseases and Wnt signalling.
Given the lack
of definitive AD biomarkers in humans,
transgenic animal models of the amyloid pathology continue to be valuable tools to examine molecular changes preceding the deposition
of amyloid plaques and associated pathology (i.e. late inflammation, neuritic dystrophy, etc.).
While a post-doctoral fellow at the University
of Cincinnati College
of Medicine, he succeeded in establishing a variety
of useful
transgenic animal models to elucidate mechanisms
of cardiac excitation - contraction coupling and heart failure.
Scientific meeting «Gene targeting, genome editing & transgenesis: research application» We are organizing joint meeting with our colleagues from Masaryk University in Brno dedicated to current progress in
transgenic technologies in research application,
animal models of diseases and Wnt signalling.
Moreover, knock in
animal models for syngeneic studies and allowing us to isolate
transgenic armed effector cells are developed in order to show proof
of concept for the diverse applicability
of our modular targeting systems including for tumor diseases, autoimmune diseases, GvHD, transplantation / rejection as well as viral infections.